Prognostic value of hypoxia inducible factor 1α in esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 24, Issue 3, 2011, Pages 177-181

  Munipalle, P C ^a   Viswanath, Y K S ^a   Davis, P A ^a   Scoones, D ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Esophageal squamous cell cancer; Hypoxia inducible factor 1 ; Prognostic factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79954498235     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01122.x     Document Type: Article

References (20)

1. Bosetti C, Levi F, Ferlay J etal. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 2008; 122: 1118-29.
2. [Cited 14 Jul 2010.] Available from URL.
3. Vallbohmer D, Lenz H J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 2006; 19: 425-32.
4. Sobin L H, Wittekind Ch, (eds). UICC: TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002.
5. Wang G L, Jiang B H, Rue E A, Semenza G L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92: 5510-4.
6. Semenza G L. Involvement of hypoxia inducible factor 1 in human cancer. Intern Med 2002; 41: 79-83.
7. Quintero M, Mackenzie N, Brennan P A. Hypoxia inducible factor 1(HIF 1) in cancer. Eur J Surg Oncol 2004; 30: 465-8.
8. Kimura S, Kitadai Y, Tanaka S etal. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumor angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer 2004; 40: 1904-12.
9. Semenza G L. Hypoxia, clonal selection, and the role of HIF 1 in tumor progression. Crit Rev Biochem Mol Biol 2000; 35: 71-103.
10. Shi Y H, Fang W G. Hypoxia-inducible factor-1 in tumor angiogenesis. World J Gastroenterol 2004; 10: 1082-7.
11. Bos R, van der Greijer A E, Shvarts A etal. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003; 97: 1573-81.
12. Katsuta M, Miyashita M, Makino H etal. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 2005; 78: 123-30.
13. Kurokawa T, Miyamoto M, Kato K etal. Overexpression of hypoxia inducible factor 1α in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 2003; 89: 1042-7.
14. Matsuyama T, Nakanishi K, Hayashi T etal. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma. Cancer Sci 2005; 96: 176-82.
15. Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia induxible factor (HIF)-1α expression. Pathol Oncol Res 2009; 15: 487-93.
16. Ling F C, Leimbach N, Baldus S E etal. HIF-1alpha mRNA is not associated with histopathological regression following neoadjuvant chemoradiation in esophageal cancer. Anticancer Res 2006; 26: 4505-9.
17. Koukourakis M, Giatromanolaki A, Skarlatos J etal. Hypoxia inducible factor (HIF 1α and HIF 2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 2001; 61: 1830-2.
18. Sohda M, Ishikawa H, Masuda N etal. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 2004; 110: 838-44.
19. Yeo E J, Chun Y S, Park J W. New anticancer strategies targeting HIF-1. Biochem Pharmacol 2004; 68: 1061-9.
20. Tan C, de Noronha R G, Roecker A J etal. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 2005; 65: 605-12.